CRO Pivotal inks investigator-sponsored trial deal for genitourinary cancers

10:26 EDT 5 Jul 2018 | Outsourcing-Pharma

CRO Pivotal is collaborating with the non-profit cancer research association APRO to advance investigator-sponsored trials in bladder and prostate cancers.

More From BioPortfolio on "CRO Pivotal inks investigator-sponsored trial deal for genitourinary cancers"